Subtype
Central Nervous System Hemangioblastoma
CI-CAN-00002139Explore in graph →
Non-malignant1 active trials
- NCIt
- C7007
Loading cancer entity…
Subtype
CI-CAN-00002139Explore in graph →
Clinical trials
3 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04458935 | Retrospective Case Series of Trans-scleral Cryotherapy for Retinal Hemangioblastoma | completed | — | 25 | National Eye Institute (NEI)NIH | 1 | Jun 10, 2026 | clinicaltrials |
| NCT05424016 | Propranolol and Von Hippel-Lindau Disease(PRO-HEB) | recruiting | N/A | 85 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Dec 13, 2023 | clinicaltrials |
| NCT00052013 | Treatment of Von Hippel-Lindau (VHL)-Related Hemangioblastoma With PTK787/ZK 222584 | completed | Phase 2 | 11 | Novartis PharmaceuticalsINDUSTRY | 1 | Mar 6, 2017 | clinicaltrials |
Data updated 22 days agoSource updated Jun 10, 2026source: clinicaltrials